Italy Hormonal Contraceptive Market Size & Outlook
Related Markets
Italy hormonal contraceptive market highlights
- The Italy hormonal contraceptive market generated a revenue of USD 451.0 million in 2024 and is expected to reach USD 526.9 million by 2030.
- The Italy market is expected to grow at a CAGR of 2.6% from 2025 to 2030.
- In terms of segment, pill was the largest revenue generating method in 2024.
- IUD is the most lucrative method segment registering the fastest growth during the forecast period.
Hormonal contraceptive market data book summary
Market revenue in 2024 | USD 451.0 million |
Market revenue in 2030 | USD 526.9 million |
Growth rate | 2.6% (CAGR from 2025 to 2030) |
Largest segment | Pill |
Fastest growing segment | IUD |
Historical data | 2018 - 2023 |
Base year | 2024 |
Forecast period | 2025 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Pill, IUD, Injectable, Vaginal Ring, Implant, Patch |
Key market players worldwide | AbbVie Inc, Afaxys, Teva Pharmaceutical Industries Ltd, Bayer AG, Organon Group of Companies, Pfizer Inc, Agile Therapeutics Inc, Janssen Pharmaceuticals NV, Lupin, Pregna International |
Other key industry trends
- In terms of revenue, Italy accounted for 2.7% of the global hormonal contraceptive market in 2024.
- Country-wise, U.S. is expected to lead the global market in terms of revenue in 2030.
- In Europe, Germany hormonal contraceptive market is projected to lead the regional market in terms of revenue in 2030.
- Spain is the fastest growing regional market in Europe and is projected to reach USD 456.0 million by 2030.
No credit card required*
Horizon in a snapshot
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more
Hormonal Contraceptive Market Scope
Hormonal Contraceptive Market Companies
Name | Profile | # Employees | HQ | Website |
---|---|---|---|---|
Organon Group of Companies | View profile | - | - | - |
Janssen Pharmaceuticals NV | View profile | - | - | - |
Pregna International | View profile | 51-100 | Mumbai, Maharashtra, India, Asia | https://www.pregna.com/ |
Afaxys | View profile | 1-10 | Charleston, South Carolina, United States, North America | https://www.afaxys.com/ |
Agile Therapeutics Inc | View profile | 19 | 500 College Road East, Suite 310, Princeton, NJ, United States, 08540 | https://www.agiletherapeutics.com |
Bayer AG | View profile | 99723 | Kaiser-Wilhelm-Allee 1, Leverkusen, NW, Germany, 51368 | https://www.bayer.com |
Lupin | View profile | 10001+ | Mumbai, Maharashtra, India, Asia | https://www.lupin.com |
Pfizer Inc | View profile | 88000 | 66 Hudson Boulevard East, New York, NY, United States, 10001-2192 | https://www.pfizer.com |
AbbVie Inc | View profile | 50000 | 1 North Waukegan Road, North Chicago, IL, United States, 60064-6400 | http://www.abbvieinvestor.com |
Teva Pharmaceutical Industries Ltd | View profile | 37851 | 124 Dvora HaNevi’a Street, Tel Aviv, Israel, 6944020 | https://www.tevapharm.com |
Italy hormonal contraceptive market outlook
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to hormonal contraceptive market will help companies and investors design strategic landscapes.
Pill was the largest segment with a revenue share of 53.02% in 2024. Horizon Databook has segmented the Italy hormonal contraceptive market based on pill, iud, injectable, vaginal ring, implant, patch covering the revenue growth of each sub-segment from 2018 to 2030.
Reasons to subscribe to Italy hormonal contraceptive market databook:
-
Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
-
Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
-
Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
-
Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
-
Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.
Target buyers of Italy hormonal contraceptive market databook
-
Our clientele includes a mix of hormonal contraceptive market companies, investment firms, advisory firms & academic institutions.
-
30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
-
Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
-
The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.
Horizon Databook provides a detailed overview of country-level data and insights on the Italy hormonal contraceptive market , including forecasts for subscribers. This country databook contains high-level insights into Italy hormonal contraceptive market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Partial client list
Italy Method - Hormonal Contraceptive Market size, 2024 - 2030 (US$M)
Italy Hormonal Contraceptive Market Outlook Share, 2024 & 2030 (US$M)
Sign up - it's easy, and free!
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account
- 30K+ Global Market Reports
- 120K+ Country Reports
- 1.2M+ Market Statistics
- 200K+ Company Profiles
- Industry insights and more